Emiddio B.
- Country
- Italy
- Department
- Dipartimento di Oncologia Medica U.O. Oncologia
Research Overview
Data & Insights
Has run more than one trial at 11 of 128 partner sites.
Specializations
Oncology Research Focus
This investigator specializes in treating non-small cell lung cancer, with particular emphasis on surgical and post-surgical therapeutic approaches.
- Resectable NSCLC Management
- Early-Stage Lung Cancer Treatment
- Post-Surgical Cancer Care
The investigator's expertise extends to adjuvant therapy strategies for various stages of lung cancer, including stages IB, II, and IIIA.
Immunotherapy Applications
The research interest centers on immunotherapeutic approaches in lung cancer treatment, particularly focusing on PD-L1 expression analysis.
- Immune Checkpoint Therapy
- Biomarker Assessment
- Targeted Treatment Strategies
A key focus area includes investigating the role of immunotherapy in the post-surgical setting for lung cancer patients.
Precision Medicine
The investigator concentrates on molecular profiling in lung cancer, particularly examining EGFR and ALK mutations for treatment planning.
- Molecular Testing
- Personalized Treatment Approaches
- Biomarker-Driven Therapy
Their work involves analyzing specific genetic markers to determine optimal treatment strategies for lung cancer patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
